Research Article
SLC2A9 Gene Polymorphism Is Associated with Elevated Serum Uric Acid Caused by Pyrazinamide
Table 5
Logistic regression analysis of risk factors leading to elevated SUA caused by pyrazinamide.
| Variables | OR | 95% CI | value |
| Gender | 1.079 | 0.431–2.703 | 0.871 | Age | 0.995 | 0.968–1.022 | 0.701 |
| BMI | 1.026 | 0.914–1.151 | 0.665 | Hypertension | 0.502 | 0.199–1.265 | 0.144 |
| Diabetes | 0.867 | 0.352–2.137 | 0.757 | Smoking history | 1.081 | 0.297–3.933 | 0.906 |
| Drinking history | 3.943 | 1.18-13.175 | | Place of residence | 0.74 | 0.323–1.695 | 0.477 |
| Initial SUA | 0.993 | 0.982–1.005 | 0.263 |
| SLC2A9 rs1014290 | AA | 1.000 | Ref. | — | GA | 0.094 | 0.023–0.386 | | GG | 0.198 | 0.035–1.129 | 0.068 |
| SLC2A9 rs13129697 | TT | 1.000 | Ref. | — | TG | 1.428 | 0.35–5.822 | 0.619 |
|
|
Abbreviation: CI, confidence interval; OR, odds ratio. The difference was statistically significant ( ). |